共 27 条
Predictive scoring model of mortality in Gram-negative bloodstream infection
被引:89
作者:
Al-Hasan, M. N.
[1
,2
]
Lahr, B. D.
[3
]
Eckel-Passow, J. E.
[3
]
Baddour, L. M.
[2
]
机构:
[1] Univ Kentucky, Div Infect Dis, Dept Med, Lexington, KY 40536 USA
[2] Mayo Clin, Dept Med, Coll Med, Div Infect Dis, Rochester, MN USA
[3] Mayo Clin, Coll Med, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA
关键词:
Bacteraemia;
outcome;
Pitt bacteraemia score;
risk factors;
sepsis;
COMBINATION ANTIBIOTIC-THERAPY;
RISK-FACTORS;
ANTIMICROBIAL THERAPY;
BETA-LACTAM;
BACTEREMIA;
MONOTHERAPY;
MANAGEMENT;
FATALITY;
OUTCOMES;
COHORT;
D O I:
10.1111/1469-0691.12085
中图分类号:
R51 [传染病];
学科分类号:
100401 ;
摘要:
Mortality is a well-recognized complication of Gram-negative bloodstream infection (BSI). The aim of this study was to develop a model to predict mortality in patients with Gram-negative BSI by using the Pitt bacteraemia score (PBS) and other clinical and laboratory variables. A cohort of 683 unique adult patients who were followed for at least 28days after admission to Mayo Clinic Hospitals with Gram-negative BSI from 1 January 2001 to 31 October 2006 and who received clinically predefined appropriate empirical antimicrobial therapy was retrospectively identified. Multivariable logistic regression was used to identify independent risk factors for 28-day all-cause mortality. Regression coefficients from a multivariable model were used to develop a risk score to predict mortality following Gram-negative BSI. Malignancy (OR3.48, 95%CI1.94-6.22), liver cirrhosis (OR5.42, 95%CI2.52-11.65), source of BSI other than urinary tract or central venous catheter infection (OR5.54, 95%CI2.42-12.69), and PBS (OR1.98, 95%CI0.92-4.25 for PBS of 2-3 and OR6.42, 95%CI3.11-13.24 for PBS4) were identified as independent risk factors for 28-day mortality in patients with Gram-negative BSI. A risk-score model was created by adding points for each independent risk factor, and had a c-statistic of 0.84. Patients with risk scores of 0, 4, 8, 12 and 16 had estimated 28-day mortality rates of approximately 0%, 3%, 14%, 45%, and 81%, respectively. The Gram-negative BSI risk score described herein estimated mortality risk with high discrimination in patients with Gram-negative BSI who received clinically adequate empirical antimicrobial therapy.
引用
收藏
页码:948 / 954
页数:7
相关论文